JP2010500286A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010500286A5 JP2010500286A5 JP2009521936A JP2009521936A JP2010500286A5 JP 2010500286 A5 JP2010500286 A5 JP 2010500286A5 JP 2009521936 A JP2009521936 A JP 2009521936A JP 2009521936 A JP2009521936 A JP 2009521936A JP 2010500286 A5 JP2010500286 A5 JP 2010500286A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- rapamycin analog
- acetate
- powder
- ray diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82031706P | 2006-07-25 | 2006-07-25 | |
| US11/781,804 US7812032B2 (en) | 2006-07-25 | 2007-07-23 | Crystalline forms of rapamycin analogs |
| US11/781,807 US7820812B2 (en) | 2006-07-25 | 2007-07-23 | Methods of manufacturing crystalline forms of rapamycin analogs |
| PCT/US2007/074159 WO2008014222A1 (en) | 2006-07-25 | 2007-07-24 | Crystalline forms of rapamycin analogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010500286A JP2010500286A (ja) | 2010-01-07 |
| JP2010500286A5 true JP2010500286A5 (https=) | 2010-09-09 |
Family
ID=38562825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009521936A Pending JP2010500286A (ja) | 2006-07-25 | 2007-07-24 | 結晶形態のラパマイシン類似体 |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP2051984A1 (https=) |
| JP (1) | JP2010500286A (https=) |
| KR (1) | KR20090035716A (https=) |
| AU (1) | AU2007276837B2 (https=) |
| BR (1) | BRPI0714945B8 (https=) |
| CA (1) | CA2658896A1 (https=) |
| IL (1) | IL196706A0 (https=) |
| MX (1) | MX2009001067A (https=) |
| NZ (1) | NZ574654A (https=) |
| WO (1) | WO2008014222A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820812B2 (en) | 2006-07-25 | 2010-10-26 | Abbott Laboratories | Methods of manufacturing crystalline forms of rapamycin analogs |
| US7812032B2 (en) | 2006-07-25 | 2010-10-12 | Abbott Laboratories | Crystalline forms of rapamycin analogs |
| CA2673991C (en) | 2007-01-21 | 2012-02-07 | Hemoteq Ag | Methods for coating catheter balloons with a defined quantity of active agent |
| US9192697B2 (en) | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
| EP2380006A4 (en) * | 2009-01-21 | 2012-05-16 | Biocon Ltd | PROCESS FOR DETERMINING THE SIROLIMUS STABILITY AND METHOD FOR PRODUCING ITS STABLE FORM |
| ES2550634T3 (es) | 2009-07-10 | 2015-11-11 | Boston Scientific Scimed, Inc. | Uso de nanocristales para un balón de suministro de fármaco |
| EP2453938B1 (en) | 2009-07-17 | 2015-08-19 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
| US8889211B2 (en) | 2010-09-02 | 2014-11-18 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
| WO2013022458A1 (en) * | 2011-08-05 | 2013-02-14 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
| WO2013028208A1 (en) | 2011-08-25 | 2013-02-28 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
| US9439892B2 (en) | 2013-05-16 | 2016-09-13 | Surmodics, Inc. | Macrolide particulates, methods for preparation, and medical devices associated therewith |
| CA2915704C (en) | 2013-06-12 | 2022-06-21 | Surmodics, Inc. | Solvent methods for preparing crystalline macrolide particulates, compositions, and articles containing particulates |
| DE102013110294B4 (de) * | 2013-09-18 | 2016-07-07 | Innora Gmbh | Limus-Depot-Formulierung auf Ballonkathetern |
| EP3435988B1 (en) | 2016-03-31 | 2021-10-06 | Surmodics, Inc. | Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment |
| US11123459B2 (en) | 2016-12-16 | 2021-09-21 | Surmodics, Inc. | Hydrophobic active agent particle coatings and methods for treatment |
| CN108144131A (zh) * | 2017-12-22 | 2018-06-12 | 上海微创医疗器械（集团）有限公司 | 一种载药植入医疗器械及其制备方法 |
| CN119431400A (zh) * | 2020-03-27 | 2025-02-14 | 波士顿科学国际有限公司 | 用于使药物结晶的方法 |
| JP2024503898A (ja) * | 2021-01-22 | 2024-01-29 | ヤンセン ファーマシューティカ エヌ．ベー． | ラパマイシン類似体及びその使用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5527907A (en) | 1993-11-19 | 1996-06-18 | Abbott Laboratories | Macrolide immunomodulators |
| US20030129215A1 (en) * | 1998-09-24 | 2003-07-10 | T-Ram, Inc. | Medical devices containing rapamycin analogs |
| US6015815A (en) * | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
| TW557297B (en) * | 1997-09-26 | 2003-10-11 | Abbott Lab | Rapamycin analogs having immunomodulatory activity, and pharmaceutical compositions containing same |
| WO2001051919A2 (en) * | 2000-01-07 | 2001-07-19 | Transform Pharmaceuticals, Inc. | High-throughput formation, identification, and analysis of diverse solid-forms |
| US7645876B2 (en) * | 2004-12-01 | 2010-01-12 | TEVA Gyógyszergyár Zártkörúen Müködö Részvénytársaság | Processes for producing crystalline macrolides |
| AR050374A1 (es) * | 2004-08-20 | 2006-10-18 | Wyeth Corp | Forma polimorfica de rafampicina |
-
2007
- 2007-07-24 JP JP2009521936A patent/JP2010500286A/ja active Pending
- 2007-07-24 AU AU2007276837A patent/AU2007276837B2/en active Active
- 2007-07-24 EP EP07799771A patent/EP2051984A1/en not_active Withdrawn
- 2007-07-24 WO PCT/US2007/074159 patent/WO2008014222A1/en not_active Ceased
- 2007-07-24 EP EP11183446A patent/EP2407471A3/en not_active Withdrawn
- 2007-07-24 NZ NZ574654A patent/NZ574654A/en unknown
- 2007-07-24 BR BRPI0714945A patent/BRPI0714945B8/pt active IP Right Grant
- 2007-07-24 CA CA002658896A patent/CA2658896A1/en not_active Abandoned
- 2007-07-24 MX MX2009001067A patent/MX2009001067A/es active IP Right Grant
- 2007-07-24 KR KR1020097003955A patent/KR20090035716A/ko not_active Ceased
-
2009
- 2009-01-25 IL IL196706A patent/IL196706A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010500286A5 (https=) | ||
| JP2010536889A5 (https=) | ||
| RU2009106470A (ru) | Кристаллические формы аналогов рапамицина | |
| JP2019514874A5 (https=) | ||
| JP2010504343A5 (https=) | ||
| JP2009530283A5 (https=) | ||
| JP2005053931A5 (https=) | ||
| JP2010540541A5 (https=) | ||
| RU2018145948A (ru) | Кристалл пирролопиримидина для получения jak-ингибитора | |
| JP2010501478A5 (https=) | ||
| JP2013505929A5 (https=) | ||
| HRP20141137T1 (hr) | Polimorfni oblici macrocikliäśkog inhibitora hcv | |
| JP2008546770A5 (https=) | ||
| JP2015508092A5 (https=) | ||
| JP2010536766A5 (https=) | ||
| JP2012092103A5 (https=) | ||
| JP2012512863A5 (https=) | ||
| JP2010539237A5 (https=) | ||
| JP2014518240A5 (https=) | ||
| US20200347047A1 (en) | Solid state form of valbenazine | |
| JP2010534246A5 (https=) | ||
| JP2010522214A5 (https=) | ||
| RU2016118796A (ru) | Новая кристаллическая форма 2-{ 3-[2-(1-{ [3, 5-бис(дифторметил)-1н-пиразол-1-ил]ацетил} пиперидин-4-ил)-1, 3-тиазол-4-ил]-4, 5-дигидро-1, 2-оксазол-5-ил} -3-хлорфенилметансульфоната | |
| JP2022060192A5 (https=) | ||
| JP2011528662A5 (https=) |